Activation of EP4 has been observed to elevate the phosphorylation levels of Akt and RGC2, leading to increased RalA GTP levels and enhanced invasion capability of RCC cells (Zhang et al., 2017). The gene discussed is PTGER4; the disease is renal cell carcinoma.